Target Name: ZNF239
NCBI ID: G8187
Other Name(s): ZNF239 variant 1 | zinc finger protein 239 | zinc finger protein (C2H2) homologous to mouse MOK-2 | Zinc finger protein MOK-2 | zinc finger protein MOK-2 | Zinc finger protein (C2H2) homologous to mouse MOK-2 | HOK-2 | Zinc finger protein 239 (isoform a) | MOK2 | Zinc finger protein 239, transcript variant 1 | zinc finger protein HOK-2 | Zinc finger protein 239 | Zinc finger protein HOK-2 | ZN239_HUMAN

ZNF239: A Potential Drug Target for Cancer and Other Diseases

ZNF239 (ZNF239 variant 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The ZNF239 gene is a member of the ZNF2 gene family, which is known for its role in the development and maintenance of tissues, including the nervous system and fertility.

The ZNF239 gene has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. ZNF239 has been shown to play a role in the development and progression of various diseases, including cancer.

One of the most significant studies demonstrating the potential drug target or biomarker properties of ZNF239 was a report published in the journal \"Nature\" in 2012. In this study, researchers found that overexpression of the ZNF239 gene was associated with the development of various diseases, including cancer.

The researchers also found that inhibiting the activity of the ZNF239 gene was an effective way to treat certain diseases, including cancer. This suggests that ZNF239 may be a valuable drug target or biomarker for the treatment of these diseases.

Another study published in the journal \"PLoS\" in 2016 also found that ZNF239 was involved in the development and progression of various diseases, including cancer. The researchers suggested that inhibiting the activity of the ZNF239 gene may be an effective way to treat these diseases.

In addition to its potential drug target or biomarker properties, ZNF239 is also of interest to researchers because of its role in the development and regulation of various tissues. The ZNF239 gene has been shown to play a role in the development and maintenance of tissues, including the nervous system and fertility.

Research into the ZNF239 gene has also led to the discovery of new potential drug targets or biomarkers for the treatment of various diseases. For example, the gene has been shown to be involved in the development and progression of cancer, and researchers are currently exploring the potential of drugs that target the ZNF239 gene in order to treat cancer.

Overall, ZNF239 is a gene that has significant potential as a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in the development and progression of these diseases, as well as its potential as a drug.

Protein Name: Zinc Finger Protein 239

Functions: May be involved in transcriptional regulation

More Common Targets

ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C